Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.27 USD
Change Today 0.00 / 0.00%
Volume 0.0
IMGN On Other Exchanges
As of 8:10 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gregory D. Perry

Former Chief Financial Officer, Principal Accounting Officer and Executive Vice President, ImmunoGen, Inc.
AgeTotal Calculated CompensationThis person is connected to 22 board members in 2 different organizations across 11 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Gregory D. Perry, also known as Greg, has been the Chief Financial & Business Officer at Eleven Biotherapeutics, Inc. since December 2013. Mr. Perry served as an Interim Chief Financial Officer of InVivo Therapeutics Holdings Corp. from September 23, 2013 to December 30, 2013. He served as the Chief Financial Officer at ImmunoGen, Inc. from 2009 to September 13, 2013 and served as its Executive Vice President from April 2011 to September 13, 2013. Mr. Perry served ...

Read Full Background

Corporate Headquarters*

830 Winter Street
Waltham, Massachusetts 02451

United States

Phone: 781-895-0600
Fax: 781-895-0611

Board Members Memberships*

Former Director
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Director, Chairman of Audit Committee and Member of Compensation Committee


Amherst College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$429,851

Stock Options*

All Other Compensation$24,000
Exercisable Options36,436
Unexercisable Options109,312
Total Number of Options145,748

Total Compensation*

Total Annual Cash Compensation$453,851
Total Short Term Compensation$429,851
Other Long Term Compensation$24,000
Total Calculated Compensation$453,851
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMGN:US $14.27 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at